Company Filing History:
Years Active: 2007-2010
Title: Innovations of Hans Georg Fliri
Introduction
Hans Georg Fliri is a notable inventor based in Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis C. With a total of 2 patents, his work has garnered attention for its potential impact on public health.
Latest Patents
Fliri's latest patents include innovative cyclosporin derivatives designed for the treatment and prevention of hepatitis C infection. These inventions relate to cyclosporin derivatives of general formula (I), wherein A, B, R, and X are defined in the specification. The pharmaceutical compositions prepared from these derivatives are aimed at effectively combating the hepatitis C virus.
Career Highlights
Fliri is currently associated with Scynexis, Inc., where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
One of his notable coworkers is David Renwick Houck, with whom he collaborates on various projects within the company.
Conclusion
Hans Georg Fliri's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a significant inventor in the fight against hepatitis C. His ongoing work at Scynexis, Inc. continues to pave the way for advancements in medical treatments.